vitamin ad3e pro injectione
bela-pharm gmbh & co. kg, lohner str. 19, 49377 vechta, njemačka - retinil palmitat (vit. a); all-rac-alfa-tokoferol acetat (vit. e); uljna otopina kolekalciferola (vit. d3) - otopina za injekciju - vitamini i minerali - goveda, konja, svinja, pasa
dasatinib alpha-medical 100 mg filmom obložene tablete
alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - дазатиниб - filmom obložena tableta - 100 mg - urbroj: jedna filmom obložena tableta sadrži 100 mg dasatiniba
dasatinib alpha-medical 20 mg filmom obložene tablete
alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - дазатиниб - filmom obložena tableta - 20 mg - urbroj: jedna filmom obložena tableta sadrži 20 mg dasatiniba.
gefitinib alpha-medical 250 mg filmom obložene tablete
alpha-medical d.o.o., dragutina golika 36, zagreb - gefitinibum - filmom obložena tableta - 250 mg - urbroj: jedna tableta sadrži 250 mg gefitiniba
blincyto
amgen europe b.v. - blinatumomab - prekursorska stanica limfoblastične leukemije-limfom - antineoplastična sredstva - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.
pemetreksed alpha-medical 500 mg prašak za koncentrat za otopinu za infuziju
alpha-medical d.o.o., dragutina golika 36, zagreb - pemetrexedum - prašak za koncentrat za otopinu za infuziju - 500 mg - urbroj: jedna bočica sadrži 500 mg pemetrekseda (kao pemetrekseddinatrij). nakon rekonstitucije svaka bočica sadrži 25 mg/ml pemetrekseda
allergodil 1 mg/1 ml sprej za nos, rastvor
mylan d.o.o. - азеластин - sprej za nos, rastvor - 1 mg/1 ml - 1 ml spreja za nos, rastvora sadrži: 1 mg (0,1 %) azelastinhidrohlorida
allergodil 1.5 mg/1 ml sprej za nos, rastvor
mylan d.o.o. - азеластин - sprej za nos, rastvor - 1.5 mg/1 ml - 1 ml spreja za nos, rastvora sadrži: 1,5 mg azelastin hidrohlorid
allergodil 1.5 mg/1 ml sprej za nos, rastvor
mylan d.o.o. - азеластин - sprej za nos, rastvor - 1.5 mg/1 ml - 1 ml spreja za nos, rastvora sadrži: 1,5 mg azelastin hidrohlorid
allergodil 1.5 mg/1 ml sprej za nos, rastvor
viatris bh d.o.o. - азеластин - sprej za nos, rastvor - 1.5 mg/1 ml - 1 ml spreja za nos, rastvora sadrži: 1,5 mg azelastin hidrohlorida